Medicaid Coverage Restrictions and On-Label Buprenorphine Prescribing for Chronic Pain

By afschroeder • February 18, 2026

Nguemeni Tiako MJ, Abrams MP, Pinto Taylor E. Medicaid Coverage Restrictions and On-Label Buprenorphine Prescribing for Chronic Pain. J Gen Intern Med. 2026 Feb 17. doi: 10.1007/s11606-026-10243-7. Epub ahead of print. PMID: 41703382.

Tags: buprenorphine, chronic pain, General Internal Medicine, medicaid, opioid epidemic, opioids, prior authorization, Publications

Endogenous sex hormones, sex hormone-binding globulin, and muscle health: insights into sarcopenia and sarcopenic obesity from the Women’s Health Initiative

Osmancevic A, Daka B, Larson JC, Allison M, Burney RO, Shadyab AH, Cauley JA, Crandall CJ. Endogenous sex hormones, sex hormone-binding globulin, and muscle health:[...]

DaRE to Approach Differently: Teaching the Digital Anorectal Examination Through a Trauma-Informed Framework

Kwan K, Labora A, Chen F, Solorzano W, Gonzalez D, Orji W, Russell T. DaRE to Approach Differently: Teaching the Digital Anorectal Examination Through a[...]

Incorporating Economic Evidence in Clinical Guidelines

Shamliyan TA, Crandall CJ, Tice JA, Owens DK, Qaseem A. Incorporating Economic Evidence in Clinical Guidelines. Ann Intern Med. 2026 Feb;179(2):319-320. doi: 10.7326/ANNALS-25-04818. PMID: 41698228.